Cancer Centers of Florida

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Metastatic breast cancer
• Ovarian cancer

Running trials

• Recruiting

  A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

  NCT07310420· Phase 1· TerSera Therapeutics LLC· Source

  Contact: Gopal Kunta, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting